BioCentury
ARTICLE | Company News

CeNeS, Cardinal manufacturing deal

September 17, 2001 7:00 AM UTC

CeNes (LSE:CEN) and International Processing, subsidiary of Cardinal Health (CAH), will co-market CEN's Oral Sustained Action Technology (OSAT) for drug delivery in the U.S. CEN will be responsible fo...